Qiagen Marseille
2014
FOUNDED
PRIVATE
STATUS
101-200
EMPLOYEES
Series B
LATEST DEAL TYPE
$21M
LATEST DEAL AMOUNT
10
INVESTORS
Description
Developer and manufacturer of a line of immunologic scoring tests designed to investigate the immune response within the tumor environment. The company's immune-based diagnostics services and products are developed using a proprietary set of Immune biomarkers, advanced image analysis technologies to precisely measure the immune reaction in and around the tumor, enabling clinicians to determine the degree of severity of the patient's disease and to predict response to treatment.
Website
Formerly Known As
HalioDx SAS, QIAGEN Marseille (non IP-related assets), Halio-Dx, Halio Dx, QIAGEN Marseille (Non Intellectual Property Assets), HalioDx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- Luminy Biotech Entreprises
- 163 Avenue de Luminy, Marseille Cedex 9
- 13288 Marseille
- France
+33 04 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Qiagen Marseille’s full profile, request a free trial.
Qiagen Marseille Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 10-Dec-2018 | $21M | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Later Stage VC (Series A) | 15-Jun-2015 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | Completed | Startup |
Qiagen Marseille Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| ABSA | 00,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| ADP B | 00,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 |
Qiagen Marseille Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Amundi Private Equity Funds | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | ||
| Capricorn Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| VA Bio+Tech Park | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| BNP Paribas Asset Management | Asset Manager | Minority | 000 0000 | 000000 0 |
Qiagen Marseille Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »Qiagen Marseille Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Bervin Bouani | Sham Innovation Santé | Board Member | 000 0000 | |
| Christophe Somaini | Amundi Private Equity Funds | Board Observer | 000 0000 | |
| Corinne Danan | Qiagen Marseille | Executive Vice President, Partnerships BU & Board Member | 000 0000 | |
| Luc Pascal | Self | Board Observer | 000 0000 | |
| Michel Pourcelot | Sofipaca Capital Investissement | Board Observer | 000 0000 |
1 Former Board Member
You’re viewing 5 of 11 board members. Get the full list »